Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Dorota Łubgan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2569-3814; OpenAlex author ID A5025079728. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomi… Co-author DOI 10.1200/jco-25-03004↗
  2. Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO… Co-author DOI 10.1200/jco-24-01502↗
  3. R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-… Last author DOI 10.1007/s00066-020-01680-2↗
  4. [FOLFIRINOX after resection of pancreatic cancer sets new standards-systemic therapy providing an impulse for local treatment in resectable pancreatic cancer]. First author DOI 10.1007/s00066-019-01449-2↗
  5. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial. First author DOI 10.1186/s12885-019-6148-5↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sabine Semrau · 4 shared papers, 2019–2026 · strength 0.71
  2. Michael B. Ghadimi · 4 shared papers, 2019–2026 · strength 0.58
  3. Waldemar H. Uhl · 4 shared papers, 2019–2026 · strength 0.58
  4. Henriette Golcher · 4 shared papers, 2019–2026 · strength 0.58
  5. Robert Grützmann · 4 shared papers, 2019–2026 · strength 0.58
  6. Anke Reinacher‐Schick · 4 shared papers, 2019–2026 · strength 0.58
  7. Helmut Oettle · 4 shared papers, 2019–2026 · strength 0.58
  8. Uwe A. Wittel · 4 shared papers, 2019–2026 · strength 0.58
  9. Rainer Fietkau · 3 shared papers, 2021–2026 · strength 0.50
  10. Stefan Hubert Boeck · 3 shared papers, 2021–2026 · strength 0.50
  11. Andrea Tannapfel · 2 shared papers, 2025–2026 · strength 0.40
  12. Markus Hecht · 2 shared papers, 2025–2026 · strength 0.40
  13. Dirk Waldschmidt · 2 shared papers, 2025–2026 · strength 0.40
  14. Werner Hohenberger · 2 shared papers, 2019–2021 · strength 0.18
  15. Orlin Belyaev · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.